Major research collaboration agreed with Kings College London

We have recently completed a research agreement with Prof. Chris Shaw of Kings College London. Prof. Shaw is the discoverer of a mutant form of TDP43, a protein associated with sporadic form of ALS. Using both human tissue and rodent models of the disease, we intend to establish proof of concept for lead compound RDC5 in these models before moving to the clinic in ALS patients.